Sung Lee - 29 Jun 2026 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Jun 2026, 17:23:39 UTC
Prior SEC filing
29 Jun 2026
Next SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John O. Faurescu, attorney-in-fact for Mr. Lee

Key filing fact

Sung Lee filed Form 4 for CYTOKINETICS INC (CYTK) on 29 Jun 2026.

Key facts

  • This page summarizes Sung Lee's Form 4 filing for CYTOKINETICS INC (CYTK).
  • 11 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 29 Jun 2026, 17:23.

Change

  • Previous filing in this sequence was filed on 29 Jun 2026.
  • Current net transaction value: -$266,390.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001793200 Primary reporting owner

Lee Sung

Relationship
EVP, Chief Financial Officer
Address
350 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Signature
/s/ John O. Faurescu, attorney-in-fact for Mr. Lee
Signature date
29 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYTK transaction

Common Stock

Options Exercise

Transaction value
Shares
+188
Change %
+0.3%
Price
$44.36*
Shares after
63,409
Date
29 Jun 2026
Ownership
Direct
CYTK transaction

Common Stock

Options Exercise

Transaction value
Shares
+822
Change %
+1.3%
Price
$44.36*
Shares after
64,231
Date
29 Jun 2026
Ownership
Direct
CYTK transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,113
Change %
+1.7%
Price
$48.51*
Shares after
65,344
Date
29 Jun 2026
Ownership
Direct
CYTK transaction

Common Stock

Options Exercise

Transaction value
Shares
+188
Change %
+0.29%
Price
$44.36*
Shares after
65,532
Date
29 Jun 2026
Ownership
Direct
CYTK transaction

Common Stock

Options Exercise

Transaction value
Shares
+823
Change %
+1.3%
Price
$44.36*
Shares after
66,355
Date
29 Jun 2026
Ownership
Direct
CYTK transaction

Common Stock

Sale

Transaction value
$266,390
Shares
-3,134
Change %
-4.7%
Price
$85.00
Shares after
63,221
Date
29 Jun 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYTK transaction Derivative

Incentive Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-188
Change %
-2.1%
Price
$0.000000*
Shares after
8,828
Date
29 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
188
Exercise price
$44.36
CYTK transaction Derivative

Non-Qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-822
Change %
-2%
Price
$0.000000*
Shares after
40,504
Date
29 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
822
Exercise price
$44.36
CYTK transaction Derivative

Non-Qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-1,113
Change %
-2.1%
Price
$0.000000*
Shares after
52,304
Date
29 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,113
Exercise price
$48.51
CYTK transaction Derivative

Incentive Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-188
Change %
-2.1%
Price
$0.000000*
Shares after
8,640
Date
29 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
188
Exercise price
$44.36
CYTK transaction Derivative

Non-Qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-823
Change %
-2%
Price
$0.000000*
Shares after
39,681
Date
29 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
823
Exercise price
$44.36
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .